Iodine(II)-mediated radiofluorination

US9957231B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9957231-B2
Application numberUS-201615231470-A
CountryUS
Kind codeB2
Filing dateAug 8, 2016
Priority dateMar 7, 2014
Publication dateMay 1, 2018
Grant dateMay 1, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18 F is described. Processes, intermediates, reagents and radiolabelled compounds are described.

First claim

Opening claim text (preview).

What is claimed is: 1. A process for fluorodeiodination of an aromatic iodide compound comprising: (a) oxidizing an aromatic iodide compound (Ar-I), to form an iodonium compound; (b) reacting the iodonium compound with a compound of formula (A): to form an iodonium ylide; (c) reacting the iodonium ylide with a fluoride source to form an aromatic fluoride compound (Ar-F); wherein: R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic or a heterocyclic ring containing 3 to 7 carbon atoms and 0, 1, or 2 ring heteroatoms, each independently selected from N, O, and S, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 2. The process of claim 1 , wherein step (a) is performed in the presence of an oxidizing agent selected from the group consisting of sodium perborate, urea-hydrogen peroxide adduct, 1-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) (Selectfluor®), potassium peroxymonosulfate (OXONE®), dimethyldioxirane, or meta-chloroperoxybenzoic acid. 3. The process of claim 2 , wherein step (a) is performed in the presence of a carboxylate source that is an acetate source or trifluoroacetate source. 4. The process of claim 1 , wherein said iodonium product of step (a) is an iodonium compound of Formula B or Formula C: wherein Ar is an aromatic group, wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 5. The process of claim 1 , wherein step (b) is carried out in the presence of a base. 6. The process of claim 1 , wherein said iodonium ylide formed in step (b) is an iodonium ylide of Formula D: wherein Ar is an aromatic group, wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 7. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 8. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 9. The process of claim 1 , comprising isolating or purifying the iodonium ylide following step (b). 10. The process of claim 1 , wherein said fluoride source of step (c) is a fluoride salt. 11. The process of claim 1 , wherein said fluoride source comprises [ 18 F] fluoride. 12. The process of claim 11 , wherein said fluoride source is tetraethylammonium [ 18 F]fluoride. 13. A compound of Formula D: wherein: Ar is an aromatic group; and R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic or a heterocyclic ring containing 3 to 7 carbon atoms and 0, 1, or 2 ring heteroatoms, each independently selected from N, O, and S, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo; and wherein Ar is connected to the iodonium group through an aromatic ring carbon atom. 14. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula: 15. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula: 16. A process for preparing a compound according to claim 13 comprising: (a) oxidizing an aromatic iodide compound (Ar-I), to form an iodonium compound; (b) reacting the iodonium compound with a compound of formula (A): wherein Z 1 , Z 2 , R A and R B are as defined in claim 13 , to form a compound according to claim 13 . 17. A process for preparing an aromatic fluoride compound (Ar-F) comprising (c) reacting a compound according to claim 13 with a fluoride source to form an aromatic fluoride compound. 18. The process of claim 17 , wherein said fluoride source of step (c) is a fluoride salt. 19. The process of claim 17 , wherein said fluoride source comprises [ 18 F] fluoride. 20. The process of claim 19 , wherein said fluoride source is tetraethylammonium [ 18 F]fluoride. 21. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic ring, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 22. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached, form a 3, 4, 5, 6, or 7-membered carbocyclic ring, wherein the ring formed by the combination of R A and R B is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from halogen, C 1-6 alkyl, C 2-6 alkenyl, C 2-6 alkynyl, C 1-6 haloalkyl, C 1-6 hydroxyalkyl, and oxo. 23. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclobutyl, cyclopentyl, or cyclohexyl ring. 24. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclobutyl, cyclopentyl, or cyclohexyl ring. 25. The process of claim 1 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclopentyl ring. 26. The compound of claim 13 , wherein R A and R B in combination, together with the carbon atom to which R A and R B are attached form a cyclopentyl ring. 27. The process of claim 1 , wherein the compound of Formula A is a compound of the following formula: 28. The compound of claim 13 , wherein the compound of Formula D is a compound of the following formula:

Assignees

Inventors

Classifications

  • with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil · CPC title

  • substituted in position 17 by a keto group · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

  • Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton (cardanolide, bufanolide C07J19/00) · CPC title

  • not condensed with other rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9957231B2 cover?
A process for fluorination of aromatic compounds employing iodonium ylides and applicable to radiofluorination using 18 F is described. Processes, intermediates, reagents and radiolabelled compounds are described.
Who is the assignee on this patent?
Massachusetts Gen Hospital
What technology area does this patent fall under?
Primary CPC classification C07D213/57. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).